v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jul. 03, 2026
Jul. 04, 2025
Cash flows from operating activities:    
Net income (loss) $ (9,486) $ (92,253)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 144,381 142,986
Stock-based compensation expense 17,718 16,075
Non-cash interest expense 3,506 3,203
Fair value loss on contingent acquisition shares 0 1,787
Deferred income tax benefit (42,200) (3,673)
Loss on sale of property, plant and equipment 768 848
Changes in operating assets and liabilities:    
Trade receivables, net (3,263) (20,824)
Inventories, net (21,742) (57,282)
Accounts payable 4,980 23,161
Other operating assets and liabilities 4,321 32,145
Net cash provided by operating activities 98,983 46,173
Cash flows from investing activities:    
Purchases of property, plant and equipment and intangibles (96,699) (87,631)
Payments for acquisitions, net of cash received, and investments (1,407) (24,290)
Cash received upon settlement of derivatives 0 1,601
Net cash used in investing activities (98,106) (110,320)
Cash flows from financing activities:    
Repayments of borrowings under term credit facility (17,500) (10,000)
Proceeds from borrowings on revolving credit facilities and other 104,388 127,000
Repayments of borrowings on revolving credit facilities and other (101,897) (54,995)
Payments of tax withholding for stock-based awards (1,473) (3,447)
Proceeds from issuance of common stock, net 1,008 1,129
Deferred consideration payments and other (9,068) (2,265)
Net cash provided by (used in) financing activities (24,542) 57,422
Effect of foreign exchange rates on Cash and cash equivalents (161) 2,632
Decrease in Cash and cash equivalents (23,826) (4,093)
Cash and cash equivalents, beginning of period 36,389 48,167
Cash and cash equivalents, end of period $ 12,563 $ 44,074